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Abstract
Objective: Transthoracic echocardiography (TTE) has been used clinically to disobstruct venous drainage cannula and to optimise placement of
venous cannulae in the vena cava but it has never been used to evaluate performance capabilities. Also, little progress has been made in venous
cannula design in order to optimise venous return to the heart lung machine. We designed a self-expandable Smartcanula1 (SC) and analysed its
performance capability using echocardiography. Methods: An epicardial echocardiography probe was placed over the SC or control cannula
(CTRL) and a Doppler image was obtained. Mean (Vm) and maximum (Vmax) velocities, flow and diameter were obtained. Also, pressure drop
(DPCPB) was obtained between the central venous pressure and inlet to venous reservoir. LDH and Free Hb were also compared in 30 patients.
Comparison was made between the two groups using the student’s t-test with statistical significance established when p < 0.05. Results: Age for
the SC and CC groups were 61.6  17.6 years and 64.6  13.1 years, respectively. Weight was 70.3  11.6 kg and 72.8  14.4 kg, respectively. BSA
was 1.80  0.2 m2 and 1.82  0.2 m2, respectively. CPB times were 114  53 min and 108  44 min, respectively. Cross-clamp time was
59  15 min and 76  29 min, respectively (p = NS). Free-Hb was 568  142 U/l versus 549  271U/l post-CPB for the SC and CC, respectively
(p = NS). LDH was 335  73 mg/l versus 354  116 mg/l for the SC and CC, respectively ( p = NS). Vm was 89  10cm/s (SC) versus 63  3 cm/s
(CC), Vmax was 139  23 cm/s (SC) versus 93  11 cm/s (CC) (both p < 0.01).DPCPB was 30  10 mmHg (SC) versus 43  13 mmHg (CC) ( p < 0.05).
A Bland—Altman test showed good agreement between the two devices used concerning flow rate calculations between CPB and TTE (bias
300 ml  700 ml standard deviation). Conclusions: This novel Smartcanula design, due to its self-expanding principle, provides superior flow
characteristics compared to classic two stage venous cannula used for adult CPB surgery. No detrimental effects were observed concerning blood
damage. Echocardiography was effective in analysing venous cannula performance and velocity patterns.
# 2006 Elsevier B.V. All rights reserved.
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The use of ultrasound techniques has become routine in
cardiac surgery in order to help the clinicians in optimising
diagnosis preoperatively (transthoracic echocardiography
(TTE)) and perioperatively (transoesophageal echocardio-
graphy (TOE)) by validating surgical techniques such as mitral
valvuloplasties, identifying dyskinetic myocardial zones
postcoronary artery bypass graft (CABG) procedures and
assuring the absence of paravalvular leaks postvalve
replacement.
Recently, its usefulness has been reviewed and demon-
strated in off-pump coronary artery bypass (OPCAB) [1] and
during on-pump cardiopulmonary bypass (CPB) procedures
[2].* Corresponding author. Tel.: +41 21 3142153; fax: +41 21 3142158.
E-mail address: David.Jegger@chuv.hospvd.ch (D. Jegger).
1010-7940/$ — see front matter # 2006 Elsevier B.V. All rights reserved.
doi:10.1016/j.ejcts.2005.12.050Novel applications for TTE or TOE was already introduced
several years ago such as evaluating the correct positioning of
femoral CPB cannulae, ventricular assist device (VAD) and the
intra aortic balloon pump catheter (IABP) [3,4]. With the
inception of minimally invasive procedures such as Port-
access, TOE was also utilised with success [5,6].
Recently, diverse applications such as placement of
umbilical venous catheter, haemodialysis and jugular vein
cannulation have been reported with TOE [7—9]. Specific to
cardiac applications, TOE has been used to disobstruct
venous drainage cannula and to optimise placement of
venous cannulae in the inferior vena cava (IVC) [10—12].
Since the inception of CPB, little progress has been made
in the design of venous cannula except for minimally invasive
applications [13] and three-stage venous cannula [14].
However, a self-expanding cannula, Smartcanula1 (SC),
was developed and tested using computational fluid
dynamics (CFD) [15], in vitro [16] and in in vivo animal
settings [17]. During all of the above tests, it was found to be
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Table 1
Patient demographics and operative data of the study population
Group CTRL (n = 6) Group SC (n = 7)
Age (years) 64.6  13.1 61.6  17.6
Gender (male/female ratio) 6/0 4/3 *
Body surface area (m2) 1.82  0.2 1.80  0.2
Ejection fraction (%) 58.4  8.6 55.0  10.4
CPB time (min) 108  44 114  53
Cross-clamp time (min) 76  29 59  15
Weight (kg) 72.8  14.4 70.3  11.6
CABG (n and %) 2 (33%) 2 (29%)
Valve (n and %) 1 (17%) 4 (57%) *
Combined (n and %) 2 (33%) 0 (0%) *
Other (n and %) 1 (17%) 1 (14%)
CTRL: control group versus SC: smartcanula group; CPB: cardiopulmonary
bypass; CABG: coronary artery bypass graft.
* Statistical significance found between the two groups when p < 0.05.superior compared to classic venous cannula used for CPB
applications.
Therefore, the aim of this study was twofold: (1) to
establish the feasibility of using echocardiography (E) to
evaluate the performance of venous cannula; and (2) to
compare the SC with a control one to establish which is
superior.2. Materials and methods
The study design was approved by the Institutional review
board and the patient demographics are presented in Table 1.
Block randomisation was carried out and divided into a
treated group (SC, n = 7) and a control group (CTRL, n = 6).
However, only selected surgeons were implicated in the study
due to the novelty of the device and the need for adaptive
learning. Block randomisation was previously defined [18].
Briefly, it randomises n individuals into k treatments, in
blocks of size m. Randomisation reduces opportunities for
bias and confounding in experimental designs, and leads to
treatment groups, which are random samples of the
population sampled, thus helping to meet assumptions of
subsequent statistical analysis. Random allocation can be
made in blocks in order to keep the sizes of treatment groups
similar. In order to do this, youmust specify a sample size that
is divisible by the block size you choose. In turn you must
choose a block size that is divisible by the number of
treatment groups you specify. An advantage of small block
sizes is that treatment group sizes are very similar. AFig. 1. TTE longitudinal image (left) of the SC inserted with its proximal end insidedisadvantage of small block sizes is that it is possible to guess
some allocations, thus reducing blinding in the trial. An
alternative to using large block sizes is to use random
sequences of block sizes. The random block size option
selects block sizes of 2, 3, 4 or 5 at random. The
randomisation proceeds by allocating random permutations
of treatments within each block.
2.1. Anaesthesia technique
All patients received midazolam for premedication.
Anaesthesia was induced in all patients with propofol or
etomidate, opioids including fentanyl, and the muscle
relaxants pancuronium or vecuronium. All necessary mon-
itoring lines were then inserted, and anaesthesia was
maintained with propofol infusion or with anaesthetic gas
(isoflurane or sevoflurane), continuous infusion or repeated
doses of opioids, and pancuronium or vecuronium adminis-
tration as required.
2.2. Echocardiography technique
After rewarming but before weaning, a sterile sheath
(Raucodrape1, Lohmann & Rauscher International GmbH &
Co, Rengsdorf, Germany) was passed to the surgeon into
which the epicardial TTE probe (model 15-6L, Philips,
Bo¨blingen, Germany) was inserted together with transonic
gel. The probe was placed on the venous cannula at the
outlet of the right atrium. Echocardiographic longitudinal
and cross-sectional images are shown of the SC in situ
(Fig. 1). A Hewlett-Packard TTE machine (Sonos 5500,
Philips, Bo¨blingen, Germany) was used to perform the
imaging with a frame rate of 50 Hz. Once visualisation of
flow inside the cannula was possible, continual doppler
imaging was performed to obtain the maximum velocity
(Vmax in cm/s) and mean velocity (Vm in cm/s)(Fig. 2). The
diameter of the cannula was calculated by using the pointer
on the TTE machine thereby making the calculation of flow
rate (QE and QCPB, subscript E denotes echocardiography
and subscript CPB denotes cardiopulmonary bypass,
respectively) possible from the following formula: VTI
(velocity time integral using Vm  60)  CSA (cannula
surface area). Simultaneously, the pressure drop (DPCPB =
Pin  Pout) between the right atrium and the inlet of the CPB
venous reservoir was calculated by placing a DLP pressure
transducer at the inlet to the venous reservoir (DLP 60000,
Grand Rapids, MI, USA). The Pin was the central venousthe IVC and a cross-sectional view in situ (right).
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Fig. 2. Echocardiography images for the CTRL (A) and SC (B) showing velocity (mean and max) profile using continual Doppler imaging. Upper right hand image
reflects the cannula’s wall section, while the bottom image reflects the velocity over time. Notice the greater velocities obtained with the SC. (C) The chattering
phenomenon often encountered during the running of the CPB procedure. Notice how the excess negative pressure in the venous line provokes velocity variations
over time.pressure value (CVP) while the Pout was the value indicated
on the DLP pressure transducer.
2.3. The SC device
The Smartcanula1 (Smartcanula Ltd, Fribourg, Switzer-
land) is made of interlaced wires having memory shape
properties. The one end is moulded into a plastic tip, the
other end is siliconised to a 3/8-in. connector (Fig. 3). To
insert the cannula in a vessel, a guide wire is placed to
assure proper placement. The guide wire is inserted into
the cannula’s tip and through an introducer used to flatten
the cannula because of the cannula’s ability to change
shape when placed under stress. Once the cannula is in
place, the guide wire and introducer are removed, and it
expands to a larger diameter value due to the fact that the
stress is removed from the cannula’s structure. The circuit
is now connected to the cannula’s outlet which is
manufactured with a 3/8- or 1/2-in. connector.
2.4. Perfusion technique
A heart lung machine (Stockert Medizintechnik AG,
Munich, Germany), a hollow fibre membrane oxygenator
(D903 Dideco1, Mirandola, Italy or Quadrox1 Jostra
Medizintechnik AG, Hirrlingen, Germany), a conventional
tubing circuit (Dideco, Mirandola, Italy or Jostra Medizin-
technik AG, Hirrlingen, Germany) and an air—oxygenFig. 3. SC before insertion with a mandrel inside (top) and deployment when
the mandrel is removed (bottom). The SC expands to take the shape of the
inside lumen of the native vessel, i.e. the IVC (proximal end in this case).blender (Sechrist Industries, Inc., Anaheim, CA, USA) were
used in all of the procedures. The extracorporeal circuit is
primed with 1000 ml Ringer lactate, 500 ml Haes, 100 mg
Heparin (Liquemin, Hoffmann-La Roche, Basel, Switzer-
land), an antibiotic and 1 million IU Aprotinin (Trasylol,
Bayer, Zu¨rich, Switzerland) following the departmental
protocol.
2.5. Surgical technique
A midline sternotomy was performed. The pericardium
opened anteriorly to the phrenic nerve to expose the right
atrium and both venae cavae. Simultaneously, the arterial
site was prepared to expose the aorta. The patient was
anticoagulated with 3 mg/kg heparin (Liquemin, Hoffmann-
La Roche, Basel, Switzerland) before cannulation of the
aorta. Subsequent superior vena cava (SVC) and inferior vena
cava (IVC) cannulation occurs or direct cannulation of the
right atrium depending on the surgical procedure. CPB was
initiated with passive venous drainage. The cardiac proce-
dure was performed under direct vision. After rewarming and
careful deairing manoeuvres by way of a vent placed in the
ascending aorta, the aorta was unclamped. The weaning
process was started once the patient was ventilated and
cardiac rhythm reinitiated.
2.6. Measurements
Age, weight, body surface area (BSA), CPB and cross-
clamp times were recorded. Vmax (cm/s), Vm (cm/s), DPCPB
(mmHg), diameter, CSA of analysed section (mm) and QE (l/
min) were also recorded. Free Hb and LDH values were also
compared between the two groups.
2.7. Data analysis
(1) Mean and standard deviation were derived for each
parameter analysed. An unpaired Student’s t-test and
analysis of variance for repeated measures were used for
determination of statistical significance between the
two groups ( p < 0.05).(2) We performed a Bland—Altman analysis between QCPB
and QE rate (l/min) using GraphPad Prism version 4.00
for Windows (GraphPad Software, San Diego, CA, USA)
[19].
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Table 2
Free Hb (mg/l) and LDH (U/l), performance parameters compared between
the two groups: Vmax (cm/s), Vm (cm/s), DPCPB (mmHg), diameter of analysed
section (cm) and CSA (cm2)
Free Hb (mg/l) LDH (U/l) Vm (cm/s)
CTRL 549  271 354  116 63  3
SC 568  142 335  73 89  10y
Diameter (cm) CSA (cm2) Vmax (cm/s)
CTRL 1.27 1.27 93  11
SC 0.95 0.71 139  23y
QE (ml/min) QCPB (ml/min) DPCPB (mmHg)
CTRL 4800  200 4500  550 43  13
SC 3800  400y 4400  540 30  10 *
Parameters indexed: Vm indexed to flow rate; Vm and QCPB indexed to diameter
and CSA.
* Statistical significance found between the two groups when p < 0.05.
y Statistical significance found between the two groups when p < 0.01.3. Results
The patient demographics are presented in Table 1.
Significant differences in patient demographics were
observed between the two groups for gender, valve and
combined procedures.
In order to exclude any detrimental effects of the wire-
interlaced design on the intimal vessel wall, Free Hb and LDH
values were both comparable between the two groups
(Table 2). The SC expressed 30% greater Vm values and 33%
greater Vmax values compared to the CTRL (p < 0.001,
Table 2). When DPCPB was analysed, lower values of
30 10 mmHg versus 43  13 mmHg were observed for the
SC and CTRL, respectively (p < 0.05, Table 2).QCPBwas comp-
arable between the two groups. However, QE was significantly
different when compared between the two groups.
A Bland—Altman analysis showed good agreement
between the two devices used concerning flow rate
calculations between CPB and echocardiography (bias
300  700 ml standard deviation). This means that echocar-
diography slightly underestimated actual flow rates (Fig. 4).Fig. 4. Bland—Altman analysis of QE and QCPB; subscript E denotes echocar-
diography and subscript CPB denotes cardiopulmonary bypass, respectively.
The y-axis presents the differences between the two measuring techniques.
The x-axis represents the mean values of the two measuring techniques.
Dashed lines indicate mean differences; dotted lines indicate boundaries of
two standard deviations of the differences.All patients underwent successful CPB weaning with
minimal inotropic support and were transferred to the
intensive care unit in a stable condition. There were no
complications reported: neither postoperative organ dys-
function nor any other complication related to this
technique. Echocardiographic control at day 7 was normal
in every patient. The mortality of the patients were zero in
both groups; also the median hospital stay was 11 days for
both groups.4. Discussion
We were successfully able to evaluate venous cannula
performance with the use of echocardiography. Moreover,
the SC significantly outperformed the CTRL cannula with
respect to all flow dynamic variables measured. No
haemolysis was observed by the SC during the study period.
During a numerical analysis using CFD, Mueller et al. [15]
established lower pressure gradients across the SC which we
can advocate and validate in our study performed in a clinical
setting with a 30% lower DPCPB observed (Table 2). Moreover,
significantly greater mean and maximum velocities were
attained for the SC for an equivalent flow rate when
compared to the CTRL (Table 2). Due to the fact that higher
velocities are measured within the SC, greater resistance to
blood flow is encountered outside the patient or in the venous
line. However, the DPCPB is lower; thus, resistance to blood
flow inside the patient (CVP) is lower which supports the
superiority of the SC by showing its ability to reduce the CVP
when compared to the CTRL cannula. Jegger et al. [16,17],
also showed superiority of the SC in an in vitro setting
demonstrating 14—19% greater flow rates depending on the
preload used. This phenomenon was complemented by
performing in vivo animal testing with the SC exhibiting a
20% greater flow rate capacity during passive and active
venous drainage techniques [20]. Similar findings were
encountered by Mueller et al. [21] in a parallel bovine
experiment. Undertaking clinical comparisons is difficult as
once theoretical flow is attained, it is also maintained.
Nevertheless, comparable flow rates of 4.8  0.2 l/min and
4.4  0.5 l/min for the CTRL and SC, respectively, were
obtained. In our study, no additional haemolysis was
associated with the use of the SC compared to the CTRL as
LDH and Free Hb values were comparable (Table 2). In
addition, after each CPB procedure with the smartcannula,
the cannula was examined macroscopically with no deposits
being found. Also, the cannulae were rinsed and visually
inspected again in the absence of any thrombotic material in
or around the cannulae.
TTE has previously been reported by Grooters et al. [22] in
a clinical setting analysing the velocities at the outlet of
several commercially available arterial CPB cannula. The
intention was to evaluate whether cannula design influenced
velocities and thus reduced the tendency of atherosclerotic
emboli being a major cause of morbidity and mortality in the
cardiac surgical community. Also, TTE has already been
utilised to improve outcome when used to guide aortic
cannula during on-pump CABG procedures. The use of this
technique significantly reduced perioperative stroke and
death [2]. Recently, the use of intraoperative epiaortic
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atheroma. A correlation was established between ather-
omatous finding in the ascending aorta detected by EAUS and
the presence of peripheral vascular disease. Additionally,
surgical technique was altered in 24% of the population due
to atheromatous finding. The changes in surgical technique
included conversion from on-pump to OPCAB, change in
cannulation, aortic cross-clamping or saphenous vein graft
proximal anastomosis site. More importantly, no cerebral
vascular accidents were observed in the patients with a
pathologic aorta who were converted to off-pump CABG
surgery [23].
This novel analysis has not been performed with venous
cannula. However, TTE was used to determine the position of
the cannula relative to the IVC or right hepatic vein (RHV). It
was observed that malposition of the venous cannula into the
RHV was observed in 10% of the study population. When
analysing the data, itwas also observed that the incidencewas
greater with single stage compared to two-stage cannula. It is
speculated that position of the cannula deep inside the IVC is
more deleterious than the positioning of it in the RHV [11].
Upon the onset of CPB or during vital manipulations during
the surgical procedure, QCPB can often take several seconds or
minutes to stabilise,which are represented by a constant level
of blood in the venous reservoir. However, when QE is utilised,
it is performed instantaneously or in real time and the waiting
period for stabilisation of blood in the venous reservoir is
substantially reduced. This is advantageous as not only
instantaneous flow is measured but also change in flow
patterns, such as chattering (Fig. 3C), can be identified and
corrected. This improves patient safety as venous drainage is
optimised, maintained and assured during the CPB procedure.
The TTE technique can be considered a valid one due to
the fact that the Bland—Altman analysis depicts small bias
values when comparing the two methods. Also, the standard
deviation is less than 10% of the theoretical flow rates often
observed during CPB.
In conclusion, this study emphasises the benefit of using
TTE in evaluating venous cannula performance and at the
same time could be used to visualise correct placement of it
in the right atrium. More so, the SC outperforms the CTRL one
using this novel technique. This unique Smartcanula design,
due to its self-expanding principle, provides superior flow
characteristics compared to classic two stage venous cannula
used for adult CPB surgery. Additionally, no haemolysis was
observed in this clinical setting.Acknowledgement
Special thanks to Hewlett-Packard (Switzerland) for the
loaning of the TTE probe during the duration of the study
period.
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